1Wang LD, Zheng S. The mechanism of esophageal and gastric cardia carcinogenesis from the subjects at high-incidence area for esophageal cancer in henan. Zhengzhou Daxue Xuebao 2002;37:717-729.
2Wang LD, Zhou Q, Feng CW, Liu B, Qi YJ, Zhang YR, Gao SS,Fan ZM, Zhou Y, Yang CS, Wei JP, Zheng S. Intervention and follow-up on human esophageal precancerous lesions in Henan,northern China, a high-incidence area for esophageal cancer.Gan To Kagaku Ryoho 2002; 29(Suppl 1): 159-172.
3Hanash SM, Bobek MP, Rickman DS, Williams T, Rouillard JM, Kuick R, Puravs E. Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2002; 2:69-75.
4Anderson NL, Anderson NG. The human plasma proteome:history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1:845-867.
5Simpson RJ. Proteins and Proteomics. A Laboratory Manual.1st. New York Cold Spring Harbor Laboratory Press 2003:75-76.
6Bini L, Magi B, Marzocchi B, Arcuri F, Tripodi S, Cintorino M,Sanchez JC, Frutiger S, Hughes G, Pallini V, Hochstrasser DF,Tosi P. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 1997;18:2832-2841.
7Yamada T. Serum amyloid A (SAA): a concise review of biology,assay methods and clinical usefulness. Clin Chem Lab Med 1999;37:381-388.
8Watson G, See CG, Woo P. Use of somatic cell hybrids and fluorescence in situ hybridization to localize the functional serum amyloid A (SAA) genes to chromosome 11p15.4-p15.1 and the entire SAA superfamily to chromosome 11p15. Genomics 1994; 23:694-696.
9d'Eril GM, Anesi A, Maggiore M, Leoni V. Biological variation of serum amyloid A in healthy subjects. Clin Chem 2001; 47:1498-1499.
10Cho WC, Yip TT, Yip C, Yip V, Thulasiraman V, Ngan RK, Yip TT, Lau WH, Au JS, Law SC, Cheng WW, Ma VW, Lim CK.Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 2004; 10(1 Pt 1): 43-52.
